Introduction {#s1}
============

In recent years, genome-editing systems and their delivery technologies have progressed remarkably \[[@r29]\]. Application of such advanced systems and technologies to mouse zygotes enabled simple and quick generation of genetically modified (GM) mice. To generate GM mice, a microinjection technique has mainly been used with the clustered regularly interspaced short palindromic repeats (CRISPR)--CRISPR-associated protein 9 (Cas9) system. Although microinjection is a reliable and well-established method, it is time-consuming and difficult to master. To resolve this problem, various alternative delivery methods have been developed \[[@r23]\]. In particular, electroporation methods have often been used recently because of their easy handling and speed. Initially, single guide RNA (gRNA) and Cas9 mRNA were used for electroporation; however, efficient production of GM mice was subsequently reported by many groups using gRNA and Cas9 recombinant protein with or without a single-stranded oligodeoxynucleotide (ssODN) donor \[[@r2], [@r4], [@r8], [@r22], [@r28]\]. The gRNA and Cas9 protein form a complex, and then introduce DNA double-strand breaks (DSBs) at the targeted locus. DSBs are mainly repaired by the nonhomologous end-joining (NHEJ) pathway, and errors in this repair lead to mutations. Furthermore, by using ssODN carrying objective base arrangements such as single amino acid modifications with Cas9 ribonucleoprotein (RNP) consisting of gRNA and Cas9 protein, mice with knock-in at a particular position can be generated.

To date, fresh zygotes created by *in vitro* fertilization (IVF) or mating have typically been used for electroporation \[[@r2], [@r4],[@r5],[@r6], [@r8], [@r22], [@r28]\]. Fresh zygotes are easy to use, but they cannot be obtained at any time without exact scheduling to prepare female mice and administer hormones for superovulation. To achieve flexible scheduling and beneficial work efficiency, we previously reported the generation of various genome-edited mice by microinjection into vitrified/warmed zygotes. Efficient production of GM mice was confirmed by combining genome-editing technology with reproductive engineering techniques \[[@r17], [@r19],[@r20],[@r21]\], such as our IVF method, providing high fertility using methyl-beta-cyclodextrin (MBCD)-treated sperm and reduced glutathione (GSH)-treated oocytes (CARD method) \[[@r26]\]; ultra-superovulation treatment of female mice, by which approximately 2--3 times as many oocytes can be collected per female mouse compared with the conventional superovulation method \[[@r27]\]; and vitrification/warming of fertilized oocytes \[[@r16]\]. However, the applicability of vitrified/warmed zygotes created by such advanced reproductive engineering technologies in electroporation-mediated genome editing has not yet been fully investigated.

Here, to create an updated, streamlined pipeline of generating GM mice by combining electroporation of Cas9 RNP with reproductive engineering techniques, we used fresh or vitrified/warmed zygotes created by IVF (CARD method) via ultra-superovulation for electroporation ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1.Schematic overview of this study. Ultra-superovulation treatment was performed on C57BL/6J female mice at 4 or 11--12 weeks of age, which were then used for IVF. Created fresh fertilized oocytes were used for electroporation, followed by embryo transfer at the two-cell stage on the following day, for initial evaluation of the efficiency of generating genome-edited mice. Subsequently, the vitrification/warming technology was combined to establish the "CREATRE" method, for the flexibly scheduled, efficient generation of genome-edited mice. In the CREATRE method, electroporation was carried out using vitrified/warmed zygotes, and then one- or two-cell transfer was performed. Each pup was analyzed and identified as a genome-edited or unedited mouse.). Fresh zygotes were used for electroporation after 6.5--7.5 h from insemination (around E0.3). Vitrified/warmed zygotes were cultured for 1--5 h and then used for electroporation at different timings (E0.3--E0.5), similar to the approach using microinjection as described in our previous report \[[@r21]\]. After electroporation, the surviving one-cell zygotes or two-cell embryos were transferred to pseudopregnant female mice after culture for about 1 h or overnight, to examine whether different birth rates occurred.

Materials and Methods {#s2}
=====================

gRNA synthesis and preparation of Cas9 protein and ssODN
--------------------------------------------------------

*In vitro*-transcribed gRNAs were prepared in accordance with a previous report \[[@r1]\]. Briefly, template DNA fragments were generated using PCR amplification from CRISPR--Cas9 vectors with primers containing a T7 promoter sequence, in accordance with a previously described protocol \[[@r20]\]. Subsequently, the gRNAs were synthesized using a MEGAshortscript T7 Kit (Thermo Fisher Scientific, Tokyo, Japan), and then purified with a MEGAclear Kit (Thermo Fisher Scientific). The gRNA designs of interleukin-11 *(Il11),* tyrosinase (*Tyr*), and secreted phosphoprotein 1 (*Spp1*) genes were as described previously \[[@r20], [@r21]\]. In the generation of *Il11* mutant mice, gRNA B was synthesized and used as shown in a previous report. Recombinant Cas9 protein was obtained from Integrated DNA Technologies Japan (Alt-R^TM^ S.p. Cas9 Nuclease 3NLS; Tokyo, Japan). The sequence of ssODN for three-base substitution at the *Spp1* locus was the same as in previous reports \[[@r20], [@r21]\]. ssODN was synthesized by Integrated DNA Technologies (Coralville, IA, USA).

Animals
-------

C57BL/6J mice were purchased from CLEA Japan (Tokyo, Japan). After breeding, C57BL/6J female mice were used as oocyte donors at 4 or 11--12 weeks of age. C57BL/6J male mice over 10 weeks of age were used as sperm donors for IVF. ICR mice at 8--20 weeks of age were used as recipients of zygotes. All animals were housed under a 12-h dark--light cycle (light from 07:00 to 19:00) at 22 ± 1°C with *ad libitum* access to food and water. All animal experiments were approved by the Animal Care and Experimentation Committee of the Center for Animal Resources and Development, Kumamoto University, and were carried out in accordance with the approved guidelines.

IVF and vitrification/warming of fertilized oocytes
---------------------------------------------------

The IVF and vitrification/warming procedures were as described previously \[[@r19],[@r20],[@r21]\]. Cauda epididymides were obtained from C57BL/6J male mice and used as a source of sperm for IVF. C57BL/6J female mice were ultra-superovulated by the intraperitoneal administration of IASe (0.1 ml of IAS and 3.75 IU eCG; CARD HyperOva^®^; Kyudo, Saga, Japan), followed 48 h later by the intraperitoneal administration of hCG (7.5 IU; Gonatropin; ASKA Pharmaceutical, Tokyo, Japan) \[[@r27]\]. The cumulus--oocyte complexes were collected in CARD MEDIUM^®^ (Kyudo), which contained 0.15 mM GSH. They were inseminated with sperm after preincubation in FERTIUP^®^ Mouse Sperm Preincubation Medium (Kyudo) for 1--1.5 h, and then were incubated at 37°C in 5% CO~2~ and 95% humidified air. After 2.5 h of incubation, the inseminated oocytes were rinsed three times with modified human tubal fluid (mHTF) medium containing a high level of calcium. The generated fertilized oocytes were used for electroporation or cryopreserved by a simple vitrification method 6.5 h after insemination \[[@r15], [@r16]\]. At later time points, the cryopreserved oocytes were warmed, cultured in potassium simplex optimized medium with amino acids (KSOM-AA) for 1--5 h at 37°C in 5% CO~2~ and 95% humidified air, and used for electroporation. Descriptions of IVF and vitrification procedures are available as online manuals on our website (http://card.medic.kumamoto-u.ac.jp/card/english/sigen/manual/onlinemanual.html).

Electroporation and transfer
----------------------------

Electroporation was performed based on a previous report \[[@r4]\]. Zygotes were rinsed with Opti-MEM I (Thermo Fisher Scientific) and then placed in the electrode gap filled with 5 *µ*l of Opti-MEM I solution containing Cas9 protein and gRNA with or without ssODN. Using electrode (LF501PT1-10; BEX, Tokyo, Japan) and Genome Editor (GEB15, BEX), electroporation was performed seven times under conditions of 25 or 30 V (3 ms ON + 97 ms OFF). The zygotes were rinsed with M2 medium (Sigma, Tokyo, Japan) and cultured in KSOM-AA at 37°C in 5% CO~2~ and 95% humidified air until transfer for about 1 h or overnight. Surviving one-cell zygotes or two-cell embryos were transferred to the oviducts of pseudopregnant ICR female mice.

Analysis of pups
----------------

Pup tail lysates were prepared by an alkaline lysis method and PCR was performed using KOD FX (Toyobo, Osaka, Japan) with each primer set. For the analysis of *Il11*-modified mice, the *IL11* F and R primers listed in [Supplementary Table 1](#pdf_001){ref-type="supplementary-material"} were used. Each PCR product was subjected to automatic electrophoresis using MultiNA (Shimadzu Corporation, Kyoto, Japan) and analyzed by a heteroduplex mobility assay (HMA) \[[@r18]\]. The PCR products identified as negative or weakly positive by HMA were analyzed by direct sequencing using an ABI 3130 Genetic Analyzer (Thermo Fisher Scientific) with a BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific). For the analysis of the *Tyr* gene, the eye color of each pup was confirmed (i.e., black eyes or albinism of both eyes) and then tail lysates of pups harboring black eyes were analyzed by direct sequencing of each PCR product amplified with the *Tyr* F and R primers listed in [Supplementary Table 1](#pdf_001){ref-type="supplementary-material"}. In the *Spp1* modified mice, the *Spp1* F and R primers listed in [Supplementary Table 1](#pdf_001){ref-type="supplementary-material"} were used, and then each PCR product was subjected to restriction fragment length polymorphism (RFLP) analysis and direct sequencing, in accordance with previous reports \[[@r20], [@r21]\]. We did not perform off-target analysis of each pup, because no off-target mutations were detected previously in *Il11-* and *Tyr-*targeted founders with the same gRNA design \[[@r10], [@r19]\], and the target sequence of *Spp1*-gRNA was carefully selected using the COSMID web tool \[[@r3]\].

Results {#s3}
=======

Electroporation-mediated generation of Il11 mutant mice using fresh or vitrified/warmed zygotes
-----------------------------------------------------------------------------------------------

To examine whether reproductive engineering techniques such as IVF (CARD method) via ultra-superovulation and cryopreservation of zygotes are applicable for the generation of mutant mice using electroporation, we used Cas9 RNP with fresh or vitrified/warmed zygotes created by IVF via ultra-superovulation for the generation of *Il11* mutant mice, which were previously generated by the microinjection method and validated well \[[@r19], [@r20]\]. C57BL/6J female mice were ultra-superovulated for IVF at 4 weeks of age in the initial trials. In general, approximately 2--3 times as many oocytes can be collected per immature female mouse than per adult female mouse. The number of oocytes collected per female mouse peaks at 4 weeks of age (data not shown).

First, using fresh zygotes after IVF, we transferred surviving and developed two-cell embryos to the oviducts of pseudopregnant ICR female mice to set up various conditions for electroporation. Pups were analyzed by HMA and direct sequencing of each PCR amplicon ([Supplementary Fig. 1](#pdf_001){ref-type="supplementary-material"}). Relatively high birth rates and mutation rates were observed in all of the conditions tested, with tendencies for lower birth rates and higher mutation rates in the experimental groups using a high concentration of RNP, and higher birth rates and lower mutation rates in the experimental groups using a low concentration of RNP ([Supplementary Table 2](#pdf_001){ref-type="supplementary-material"}). These rates were almost equal to those reported by other groups who performed electroporation with RNP into fresh zygotes created by IVF \[[@r5], [@r28]\].

Next, based on our previous report, we used vitrified/warmed zygotes at different culture timings for electroporation. The condition was set as follows: RNP, 500 ng/*µ*l Cas9 and 250 ng/*µ*l gRNA; pulse, 25 V × 7, which was quite likely a foolproof condition tested in fresh zygotes ([Supplementary Table 2](#pdf_001){ref-type="supplementary-material"}). Vitrified/warmed zygotes were cultured for 1--5 h and then electroporation was performed. Subsequently, one-cell zygotes or two-cell embryos cultured overnight were transferred to pseudopregnant ICR female mice. Pups were analyzed in the same way as above. Compared with the birth rates observed using fresh zygotes, those using vitrified/warmed zygotes were almost equal or slightly decreased when embryo transfer was performed at the two-cell stage ([Table 1](#tbl_001){ref-type="table"}Table 1.Generation of *Il11* mutant mice using vitrified/warmed zygotesReagentPulseAge in weeksCulture timeElectroporatedRecoveredTransferred(2-cell embryo)Pups (%)Transferred(1-cell zygote)Pups (%)HMA+\*Sequencing+\*\*Single-peak mutation\*\*\*Mutants (%)IL11_B RNP (500 ng/*µ*l Cas9 and 250 ng/*µ*l gRNA)25 V × 741 h5251467 (15.2)----6107 (100)2 h2727256 (24.0)----4206 (100)3 h2424225 (22.7)----3225 (100)5 h50504716 (34.0)----142116 (100)2 h4646----467 (15.2)6117 (100)5 h3131----312 (6.5)1001 (50.0)11--121 h2929284 (14.3)----3104 (100)3 h2424248 (33.3)----7108 (100)5 h2323207 (35.0)----7----7 (100)2 h6361----6117 (27.9)115116 (94.1)5 h2929----295 (17.2)4105 (100)\*The numbers of HMA-positive founders are shown. \*\*The numbers of mutant mice identified by sequencing analysis are shown. \*\*\*The numbers of pups containing single-peak mutation analyzed by direct sequencing analysis are shown.). A relatively low birth rate was observed in the experimental groups with electroporation performed immediately after warming (1-h culture). Regarding the mutation rates of two-cell transfer groups, very high efficiency (\>90%) was observed in all of the conditions tested ([Table 1](#tbl_001){ref-type="table"}). However, transfer of one-cell zygotes resulted in a lower birth rate than transfer of two-cell embryos ([Table 1](#tbl_001){ref-type="table"}).

As shown in our previous report, when we generated *Il11* mutant mice by microinjection using vitrified/warmed zygotes and RNP or CRISPR--Cas9 plasmid vectors expressing gRNA and Cas9, slightly better birth rates were observed in zygotes using adult female mice as oocyte donors for IVF than in those using 4-week-old females \[[@r20]\]. To evaluate whether differences in the age of female mice used for IVF also lead to different birth rates in electroporation-mediated genome editing, we performed electroporation on vitrified/warmed zygotes using adult female mice as oocyte donors. We transferred two-cell embryos or one-cell zygotes, and then analyzed the pups. The birth rates in the experimental groups with transfer at the two-cell stage were comparable regardless of whether 4-week-old or adult female mice were used, whereas those using the zygotes derived from adult female mice showed better results in the groups with transfer at the one-cell stage ([Table 1](#tbl_001){ref-type="table"}).

Electroporation-mediated generation of Tyr mutant mice using vitrified/warmed zygotes
-------------------------------------------------------------------------------------

To investigate the reproducibility of the results observed in the generation of *Il11* mutant mice, we also generated mice with mutation of another gene, *Tyr* ([Supplementary Fig. 2A](#pdf_001){ref-type="supplementary-material"}). For this, vitrified/warmed zygotes derived from 4-week-old female mice were cultured and used for electroporation with RNP. The surviving zygotes were subsequently transferred at the one-cell stage or cultured until the next day and transferred at the two-cell stage. Foster mothers underwent cesarean section at the expected date of birth to avoid cannibalism. After confirmation of pup vitality, we examined whether each pup had albino eyes. Almost all pups had albino eyes, indicating successful mutation of the *Tyr* gene ([Table 2](#tbl_002){ref-type="table"}Table 2.Generation of *Tyr* mutant mice using vitrified/warmed zygotesReagentPulseAge in weeksCulture timeElectroporatedRecoveredTransferred(2-cell embryos)Pups (%)Transferred(1-cell zygotes)Pups (%)AlbinismSequencing+\*Mutants (%)Tyr RNP (250 ng/*µ*l Cas9 and 250 ng/*µ*l gRNA)25 V × 741 h2221212 (9.5)----2--2 (100)2 h2222223 (13.6)----213 (100)3 h2626235 (21.7)----5--5 (100)5 h2222224 (18.2)----4--4 (100)2 h2323----232 (8.7)2--2 (100)5 h2525----253 (12.0)213 (100)\*The numbers of mutant mice identified by sequencing analysis are shown.). In addition, direct sequencing analysis of PCR amplicons from two pups showing black eyes revealed that they contained a mutated allele along with the wild-type allele ([Supplementary Fig. 2B](#pdf_001){ref-type="supplementary-material"}). In summary, the *Tyr* targeting resulted in similar birth rates and mutation rates compared with the *Il11* targeting. More specifically, the birth rate was better in two-cell transfer than in one-cell transfer, a lower birth rate was observed in 1-h culture, and the mutation rates were all 100% ([Table 2](#tbl_002){ref-type="table"}). Thus, these observations were suggested to be locus-independent.

Electroporation-mediated generation of Spp1-modified mice using vitrified/warmed zygotes
----------------------------------------------------------------------------------------

Finally, we confirmed the efficiency of generating knock-in mice by electroporation using vitrified/warmed zygotes with RNP and ssODN. In accordance with our previous examinations, we generated mice with a single amino acid substitution at the *Spp1* locus \[[@r20], [@r21]\]. We previously showed that microinjection after short-term (2-h) culture of vitrified/warmed zygotes led to high knock-in efficiency, although the birth rate was relatively low under such conditions \[[@r21]\]. Based on this previous result, we used vitrified/warmed zygotes for electroporation at 1.5-h culture after warming, to achieve maximum knock-in efficiency. Electroporated zygotes were cultured overnight and then transferred to pseudopregnant ICR female mice. Pups were analyzed by RFLP analysis and direct sequencing of PCR amplicons ([Supplementary Fig. 3](#pdf_001){ref-type="supplementary-material"} and [Table 3](#tbl_003){ref-type="table"}Table 3.Generation of mice with a single amino acid substitution at the *Spp1* locus using vitrified/warmed zygotesReagentPulseAge in weeksCulture timeElectroporatedRecoveredTransferred(2-cell embryos)Pups (%)KI (%)Spp1 RNP with ssODN (500 ng/*µ*l Cas9, 250 ng/*µ*l gRNA, and 115 ng/*µ*l ssODN)25 V × 741.5 h2121215 (23.8)4 (80.0)). We observed efficient generation of knock-in mice using vitrified/warmed zygotes and RNP with ssODN for electroporation. The percentage of precise knock-in newborns was 80%, which is comparable to that under the best conditions determined in a previous study using microinjection \[[@r21]\].

Discussion {#s4}
==========

To generate GM mice efficiently while improving animal welfare and work efficiency, we have developed, improved, and combined various reproductive engineering systems, such as cryopreservation of sperm, oocytes, zygotes, and embryos, ultra-superovulation method, IVF method acquiring high fertility, cold storage and transport of embryos and sperm, and embryo transfer \[[@r7], [@r12],[@r13],[@r14],[@r15],[@r16], [@r24],[@r25],[@r26],[@r27], [@r30]\]. In addition, we have recently systematically utilized such various techniques in the context of microinjection-mediated genome editing \[[@r17],[@r18],[@r19],[@r20],[@r21]\]. However, the delivery of CRISPR--Cas9 RNP to zygotes using electroporation is much easier to handle and more efficient in simple genome editing such as gene knockout. Therefore, in this study, we updated our reproductive engineering technique-assisted pipeline for the creation of genome-edited mice by incorporating the electroporation method using CRISPR--Cas9 RNP, named "CREATRE" (CARD-based Reproductive Engineering-Assisted Technology for RNP Electroporation). Using our ultra-superovulation and IVF methods, we previously confirmed that a large number of embryos could be obtained from C57BL/6J female mice at 4 weeks of age \[[@r27]\]. To maximize the number of oocytes collected via ultra-superovulation, we investigated whether our vitrification/warming technique is applicable for the generation of GM mice using electroporation.

In the generation of *Il11* mutant mice, both fresh and vitrified/warmed zygotes well developed to pups harboring mutation(s) after electroporation and transfer. Previously, Hashimoto and colleagues reported that early-stage electroporation resulted in the production of non-mosaic mutants \[[@r5]\]. Consistent with this report, we identified several single-peak mutants by direct sequencing analysis in our examination using fresh zygotes ([Supplementary Table 2](#pdf_001){ref-type="supplementary-material"}). From our data, low-concentration RNPs were suggested to be favorable to obtain non-mosaic mutants using fresh zygotes. On the other hand, some of the high-concentration RNP-introduced vitrified/warmed zygotes were also expected to have homozygous mutations ([Table 1](#tbl_001){ref-type="table"}). More comprehensive analysis is needed to clarify the best suited protocol in the context of preferentially obtaining the non-mosaic mutants based on our CREATRE method using vitrified/warmed zygotes.

In addition, using vitrified/warmed zygotes, we examined the best timing of electroporation, optimal embryo stage of transfer, and the effect of the age of female mice used for IVF. We observed better birth rates for the transfer of two-cell embryos and when electroporation was conducted on zygotes cultured for several hours after warming, compared with those with electroporation of 1-h cultured zygotes or for one-cell-zygote transfer. Thus, we believe that vitrified/warmed zygotes should not be used for electroporation immediately after warming, and transfer to pseudopregnant female mice should be performed at the two-cell stage. One possible factor of the different birth rates observed is the timing of the interaction between blastocyst and uterus, which is important for successful implantation. Receptive uterus is related to the change from dormant to activated state of blastocyst \[[@r9], [@r31]\]. The time lag of this interaction might occur between the one-cell zygote and two-cell embryo transfer, possibly resulting in the difference of implantation and birth rates. On the other hand, when vitrified/warmed one-cell zygotes or two-cell embryos were transferred into fallopian tube on day 1 of pseudopregnancy, the difference of birth rate was not observed \[[@r11], [@r13]\]. In addition, similar examination has not been thoroughly conducted in microinjection-mediated genome editing. Thus, careful investigation is still required regarding the mechanism of these phenomena as a future study.

The age of female mice used for IVF did not affect the birth rates when using electroporation, which is inconsistent with a previous observation from a study using microinjection \[[@r20]\]. In the generation of *Tyr* mutant mice, similar results as observed for mutation at the *Il11* locus were obtained; thus, we have established a locus-independent protocol for the efficient generation of mutant mice by utilizing vitrified/warmed zygotes created by IVF using 4-week-old female mice treated with ultra-superovulation. Finally, we generated *Spp1*-modified mice by the electroporation of CRISPR--Cas9 RNP with ssODN. The efficiency of generating knock-in mice (i.e., birth rate and knock-in rate) was comparable to that confirmed in other facilities, in which fresh zygotes were used for electroporation, although the target genes differed among them \[[@r2], [@r28]\].

Taking these findings together, we generated various GM mice using vitrified/warmed zygotes by an electroporation method with high birth rate and mutation/knock-in rate. These results indicate the potential of the updated "CREATRE" procedures for the generation of GM mice with the combination of electroporation of CRISPR--Cas9 RNP and reproductive engineering techniques. Using our method, the maximum number of oocytes collected from 4-week-old female mice treated with ultra-superovulation can be utilized by IVF and electroporation to generate GM mice. We believe that our CREATRE strategy is the most valuable and convenient method of generating GM mice with regard to animal welfare, flexible scheduling and work efficiency ([Table 4](#tbl_004){ref-type="table"}Table 4.Comparison of the methodologies currently available to create genome-edited miceGeneral propertiesMicroinjectionElectroporationCost of equipmentMore expensiveLess expensiveSkills and expertiseNecessaryUnnecessaryOperationLaboriousEasyBirth rateLow--moderateModerate--highApplicable genome editing toolNo particular restrictionDifficult to introduce double-strand DNA donorSpecific propertiesMicroinjectionElectroporationConventional superovulation (eCG-hCG)MatingFresh zygotesMost generalMost generalVitrified/wormed zygotesBetter for flexible schedulingBetter for flexible scheduling and work efficiencyIVFFresh zygotesDifficult timewiseBetter for animal welfare and work efficiencyVitrified/wormed zygotesBetter for animal welfare andflexible schedulingBetter for animal welfare, flexible scheduling and work efficiencyUltra-superovulation (IASe-hCG)IVFFresh zygotesDifficult timewiseBetter for animal welfare with the maximum number of collectable oocytes and work efficiencyVitrified/wormed zygotesBetter for animal welfare with the maximum number of collectable oocytes and flexible schedulingBest at present for animal welfare with the maximum number of collectable oocytes, flexible scheduling and work efficiency (CREATRE method)).

Supplementary Material
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